Crystal Structures of Phosphodiesterases and Implications on Substrate Specificity and Inhibitor Selectivity

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 4, 2007-02 ,pp. : 391-403

Bentham Science Publishers

Access to resources Recommend Favorite

Quaternary Structure, Substrate Selectivity and Inhibitor Design for SARS 3C-Like Proteinase

By  

Current Pharmaceutical Design, Vol. 12, Iss. 35, 2006-12 ,pp. : 4555-4564

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of CYP2C8 and 2C9 polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort

By Haschke-Becher Elisabeth   Kirchheiner Julia   Trummer Olivia   Grünbacher Gerda   Kainz Alexander   Boehm Bernhard O   März Winfried   Renner Wilfried  

Pharmacogenomics, Vol. 11, Iss. 10, 2010-10 ,pp. : 1359-1365

Future Medicine

Access to resources Recommend Favorite

Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs: Clinical Relevance

By Kirchheiner Julia   Roots Ivar   Goldammer Mark   Rosenkranz Bernd  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1209-1225

Adis International

Access to resources Recommend Favorite

Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids

By Kirchheiner Julia   Meineke Ingolf   Fuhr Uwe   Rodrííguez-Antona Cristina   Lebedeva Elena   Brockmööller Jüürgen  

Pharmacogenomics, Vol. 9, Iss. 3, 2008-03 ,pp. : 277-288

Future Medicine

Access to resources Recommend Favorite